Genotypic HIV drug resistance testing examines HIV genetic material to identify mutations associated with reduced susceptibility to particular antiretroviral medicines. It is generally considered alongside a person's treatment history, laboratory results, and clinical circumstances rather than being interpreted in isolation. The test can provide useful information when healthcare professionals need to understand why a treatment regimen may not be working as expected.
Understanding Genotypic HIV Drug Resistance Testing
Genotypic testing analyzes sections of the HIV genome that can develop mutations under selective pressure from antiretroviral treatment. A laboratory identifies these genetic changes and compares them with established resistance information to determine whether they may affect specific medications.
Testing is different from simply measuring the amount of HIV in the blood. A viral load test measures how much HIV is present, while a resistance test looks for genetic changes that may influence medication effectiveness.
Important points include:
- Genetic analysis: The test looks for mutations within relevant HIV genes.
- Treatment guidance: Results can help healthcare professionals evaluate possible medication resistance.
- Treatment history matters: Previous and current antiretroviral medicines can provide important context.
- Professional interpretation: Individual mutations do not always have the same significance when considered separately.
- Testing availability: The usefulness of testing can depend on factors such as viral load and the timing of sample collection.
The test is usually performed using a blood sample. Laboratory methods amplify and sequence relevant viral genetic material before identifying mutations. Results are then interpreted using established resistance databases and clinical guidance.
When Testing May Be Considered and What Results Mean
Genotypic resistance testing may be considered when there is concern that HIV treatment is not adequately controlling the virus. It can also have a role in certain situations before starting or changing treatment, depending on clinical circumstances and applicable treatment guidelines.
A report may identify mutations in viral genes associated with resistance to different classes of antiretroviral medicines. However, the presence of a mutation does not automatically mean that every medicine in a particular class will be ineffective. The overall resistance pattern and the person's treatment history are important.
Key considerations include:
- Possible treatment failure: Resistance testing may help investigate persistent or increasing viral load despite treatment.
- Previous medication exposure: Earlier treatments can influence the interpretation of resistance findings.
- Mutation patterns: Multiple mutations may work together and influence resistance differently from an individual mutation.
- Archived resistance: Some resistant HIV variants can become less detectable after treatment changes, so historical results may remain clinically relevant.
- Expert interpretation: Healthcare professionals use laboratory findings together with current clinical information when considering treatment options.
Genotypic testing is one part of comprehensive HIV management. Regular monitoring, adherence to prescribed treatment, appropriate laboratory testing, and communication with healthcare professionals all contribute to effective care. People should not change or stop HIV medicines based solely on a resistance test report.
Understanding the purpose and limitations of genotypic HIV drug resistance testing can make laboratory results easier to discuss with a qualified healthcare professional. The test provides valuable genetic information, while treatment decisions require consideration of the complete clinical picture, including treatment history and other relevant laboratory findings.